Skip to content

In the BioHarmony Drug Report Database

Thyrotropin alfa

Thyrogen (thyrotropin alfa) is a protein pharmaceutical. Thyrotropin alfa was first approved as Thyrogen on 1998-11-30. It is used to treat thyroid neoplasms in the USA. It has been approved in Europe to treat thyroid neoplasms. The pharmaceutical is active against thyrotropin receptor.
Trade Name Thyrogen
Common Name Thyrotropin alfa
Indication thyroid neoplasms
Drug Class Tricyclic compounds; atropine derivatives
Thyrotropin alfa
Get full access now